| Autor: |
Glassman KF; Consultant, Prescott, Arizona, USA., Brugge JS; Ludwig Center, Harvard Medical Schoolgrid.471403.5, Harvard University, Boston, Massachusetts, USA., Purchio AF; Salt Lake City, Utah, USA., Kakach LT; Cargill, Inc., Wayzata, Minnesota, USA., Fuerst TR; Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland, USA., Woods RM; Consultant, Darnestown, Maryland, USA., Stover CK; Stoneham, Massachusetts, USA., Chunduru SK; Idera Pharmaceuticals, Inc., Cambridge, Massachusetts, USA., Hincks JR; ViroDefense, Inc., Chevy Chase, Maryland, USA., McKinlay MA; The Task Force for Global Health, Decatur, Georgia, USA., Nash CH; Nash Consulting, LLC, Chester Spring, Pennsylvania, USA., Pevear DC; VenatoRx Pharmaceuticals, Inc., Malvern, Pennsylvania, USA., Monath TP; Crozet BioPharma LLC, Lexington, Massachusetts, USA., Rice CM; The Rockefeller Universitygrid.134907.8, New York, New York, USA., Peters P; Hamburg, Minnesota, USA. |
